Li Z, Zhou ZL, Miao ZH, Lin LP, Feng HJ, Tong LJ, Ding J*, Li YC*. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents. J Med Chem. 52:5115-23, 2009
Zhu H, Miao ZH*, Huang M, Feng JM, Zhang ZX, Lu JJ, Cai YJ, Tong LJ, Xu YF, Qian XH, Ding J*.  Naphthalimides induce G2 phase arrest in HCT-116 cells via ATM-activated Chk2-executed pathway.  Neoplasia 11: 1226–34. 2009
Zhang C, Yang N, Yang CH, Ding HS, Luo C, Zhang Y, Wu MJ, Zhang XW, Shen X, Jiang HL, Meng LH, Ding J*.  S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and  microtubule cytoskeleton.  PLoS One. 2009;4(3):e4881.
Ren X, Dai M, Lin LP, Li PK, Ding J*. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.  Br J Pharmacol.  156 :1228-38, 2009.

上一页  [1] [2] [3] [4]  下一页